BioCentury
ARTICLE | Company News

PPD, PrimeCyte deal

December 3, 2001 8:00 AM UTC

PPDI made an equity investment in Primecyte through the purchase of preferred stock and warrants. Primecyte’s Cytection drug screening technology uses primary human tumor cells to screen for effective...